头孢哌酮钠舒巴坦钠对炎症的临床效果及其不良反应探讨

陈丽娟

（宝鸡市凤翔县中医医院药剂科，陕西 宝鸡，721400）

浏览次数：124次 下载次数：336次

摘要：

目的 观察临床上使用头孢哌酮钠舒巴坦钠治疗炎症的效果及其不良反应发生情况。方法 选取我院炎症患者200例（2014年3月至2016年8月收治），将其随机分为对照组和观察组，每组100例。对照组给予头孢他啶注射液治疗，观察组使用头孢哌酮钠舒巴坦钠治疗，比较两组的临床治疗效果、不良反应发生情况。结果 观察组患者治疗的总有效率为90.00%，明显高于对照组的72.00%（P<0.05）；观察组患者不良反应总发生率为37.00%，高于对照组的8.00%（P<0.05）。结论 头孢哌酮钠舒巴坦钠治疗炎症的临床疗效较高，但在使用中会产生一定的不良反应。

关键词：头孢哌酮钠舒巴坦钠；炎症；不良反应

中图分类号：R978.1文献标志码：A文章编号：2096-1413(2017)28-0021-02

Clinical efficacy and side effects of cefoperazone sodium and sulbactam sodium on inflammation
CHEN Li-juan
(Department of Pharmacy, Traditional Chinese Medicine Hospital of Fengxiang County, Baoji 721400, China)

ABSTRACT: Objective To observe the efficacy and side effects of cefoperazone sodium and sulbactam sodium on inflammation. Methods Two hundred cases of inflammatory patients admitted in our hospital from March 2014 to August were selected and randomly divided into control group and observation group, with 100 cases in each group. The control group was treated with ceftazidime injection, while the observation group was treated with cefoperazone sodium and sulbactam sodium, and the clinical treatment effects and adverse reactions were compared between the two groups. Results The total effective rate of the observation group was 90.00%, which was higher than 72.00% of the control group (P<0.05); the total incidence rate of adverse reactions in the observation group was 37.00%, which was higher than 8.00% of the control group (P<0.05). Conclusion Cefoperazone sodium and sulbactam sodium has high clinical efficacy in the treatment
of inflammation, but it will produce some adverse reactions.
KEYWORDS: cefoperazone sodium and sulbactam sodium; inflammation; adverse reactions

参考文献：
[1] 杨红珍.头孢哌酮钠舒巴坦钠治疗尘肺患者中重度肺部感染的临床体会[J].中外医学研究,2013,11(31):163-164.
[2] 周家杰,邓永宾,刘伟玲.头孢哌酮钠舒巴坦钠联合左氧氟沙星治疗医院获得性肺炎的临床疗效观察[J].中国临床新医学,2014,7(1):42-44.
[3] 张定祥.西药注射用头孢哌酮钠舒巴坦钠临床应用效果及不良反应分析[J].当代医学,2015,21(20):146-147.
[4] 姜永利.头孢哌酮钠舒巴坦钠的临床疗效与不良反应[J].中国医药指南,2013,11(16):119-120.
[5] 黄红铭.头孢哌酮钠/舒巴坦钠治疗AECOPD 合并肺部感染的临床效果观察[J].国外医药:抗生素分册,2014,35(6):273-275.
[6] MURTAZA S,ABBAS A,REHMAN R,et al.Comparative analysis of cefotaxime sodium and cefoperazone sodium drugs activity and their phytochemical combinations against bacteria[J].As J Chem,2015,27(5): 1704-1706.
[7] 刘春媚.分析西药药剂头孢哌酮钠舒巴坦钠的临床应用效果[J].临床医药文献杂志:电子版,2015,2(16):3270.
[8] 韩静.西药药剂头孢哌酮钠舒巴坦钠的临床应用效果分析[J].中国医药指南,2016,14(23):89-90.
[9] 孙海清.头孢哌酮钠舒巴坦钠治疗脑卒中相关性肺炎的临床疗效及对细菌清除率的影响[J].河北医学,2015,21(12):1962-1965.
[10] LI C.Fading spectrophotometric determination of cefoperazone sodium in injections by Fe~(3+)-sulfosalicylic acid system[J].As J Chem, 2013,25(14):7918-7920.
[11] 张云翼.阿奇霉素联合头孢哌酮钠舒巴坦钠对老年肺炎疗效分析[J].医疗装备,2016,29(10):140.
[12] 郭桂军.头孢哌酮钠舒巴坦钠的临床观察及不良反应分析[J].中国现代药物应用,2012,6(4):101-102.